C. Bilir Et Al. , "Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain," Journal of Human Rhythm , vol.2, no.2, pp.78-82, 2016
Bilir, C. Et Al. 2016. Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain. Journal of Human Rhythm , vol.2, no.2 , 78-82.
Bilir, C., Balık, M. S., Kızılkaya, B., Yıldırım, Ş., Görmez, S., & Bilir, F., (2016). Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain. Journal of Human Rhythm , vol.2, no.2, 78-82.
Bilir, Cemil Et Al. "Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain," Journal of Human Rhythm , vol.2, no.2, 78-82, 2016
Bilir, Cemil Et Al. "Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain." Journal of Human Rhythm , vol.2, no.2, pp.78-82, 2016
Bilir, C. Et Al. (2016) . "Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain." Journal of Human Rhythm , vol.2, no.2, pp.78-82.
@article{article, author={Cemil Bilir Et Al. }, title={Serum Lactate Dehydrogenase Levels May Predict Fentanyl Usage in Patients with Metastatic Cancers for The Treatment of Cancer Related Pain}, journal={Journal of Human Rhythm}, year=2016, pages={78-82} }